A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
OncoResponse, Inc.
OncoResponse, Inc.
Grupo Espanol de Investigacion en Sarcomas
Institut Bergonié
Hospital Universitario Virgen de la Arrixaca
University Hospital, Strasbourg, France
SpeciCare
Northwestern University
Peking University People's Hospital
Grupo de Apoio ao Adolescente e a Crianca com Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Rocky Mountain Cancer Centers
Maisonneuve-Rosemont Hospital